Mark T Bergmann Selected Research

bepotastine besilate

1/2014	Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%.
7/2010	Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark T Bergmann Research Topics

Disease

2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2014 - 07/2010
1	Hyperemia 07/2010
1	Pruritus (Itching) 07/2010

Drug/Important Bio-Agent (IBA)

2	bepotastine besilate FDA Link 01/2014 - 07/2010
2	Ophthalmic Solutions (Eye Drops)IBA 01/2014 - 07/2010
1	AllergensIBA 07/2010